Public-Private Partnerships Can Boost Innovation, Affordability Of Women’s Health Products

GlobalPost: Partnering to protect women from HIV
Zeda Rosenberg, CEO of the International Partnership for Microbicides (IPM), and Paul Stoffels, Johnson & Johnson’s chief scientific officer and chair of Janssen Pharmaceutical Companies of Johnson & Johnson

“…A new public-private partnership agreement announced last week between our organizations — the International Partnership for Microbicides (IPM), a nonprofit product developer, and the Janssen Pharmaceutical Companies of Johnson & Johnson, a major research-based pharmaceutical company — could help … ensure women have the tools to protect themselves from [HIV] infection. … Partnerships like ours are powerful solutions to the challenges of developing health products for women…” (5/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.